Payer+Provider's Health System Review
Purdue Pharma’s new subsidiaries may come under scrutiny if bankruptcy filing is made
Class-action suit against Mylan over EpiPen will go forward, judge rules
April 1, 2019
Read the full post on Becker's Hospital Review